Cronos Group Inc. (NASDAQ:CRON – Get Free Report) rose 6.1% during trading on Tuesday . The company traded as high as $2.26 and last traded at $2.26. Approximately 1,015,129 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 1,967,656 shares. The stock had previously closed at $2.13.
Cronos Group Stock Up 7.5 %
The firm has a fifty day moving average price of $2.22 and a two-hundred day moving average price of $2.39. The stock has a market capitalization of $875.47 million, a P/E ratio of -15.20 and a beta of 0.97.
Cronos Group (NASDAQ:CRON – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.02) earnings per share for the quarter. The firm had revenue of $27.76 million for the quarter, compared to the consensus estimate of $25.85 million. Cronos Group had a negative net margin of 56.43% and a negative return on equity of 2.06%. During the same quarter in the prior year, the business posted ($0.02) earnings per share. Sell-side analysts anticipate that Cronos Group Inc. will post -0.05 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Cronos Group Company Profile
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Featured Articles
- Five stocks we like better than Cronos Group
- Investing In Preferred Stock vs. Common Stock
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- The 3 Best Retail Stocks to Shop for in August
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- The 3 Best Blue-Chip Stocks to Buy Now
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.